Xia Zhao

10.8k total citations · 2 hit papers
104 papers, 7.4k citations indexed

About

Xia Zhao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xia Zhao has authored 104 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 27 papers in Oncology and 22 papers in Immunology. Recurrent topics in Xia Zhao's work include Immunotherapy and Immune Responses (10 papers), RNA Interference and Gene Delivery (8 papers) and Magnolia and Illicium research (8 papers). Xia Zhao is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), RNA Interference and Gene Delivery (8 papers) and Magnolia and Illicium research (8 papers). Xia Zhao collaborates with scholars based in China, United States and Hong Kong. Xia Zhao's co-authors include Wei Wang, Xiaoyi Hu, Jing Li, Maorong Fu, Yuquan Wei, Min Wu, Yang Yang, Weiqi Hong, Mengyuan Huang and Hongyi Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biomaterials.

In The Last Decade

Xia Zhao

100 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The JAK/STAT signaling pathway: from bench to clinic

2021 1.5k citations Xia Zhao et al. profile →
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

2020 1.2k citations Xia Zhao et al. profile →

Peers

Countries citing papers authored by Xia Zhao

Since Specialization

Citations

This map shows the geographic impact of Xia Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Zhao more than expected).

Fields of papers citing papers by Xia Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Zhao. The network helps show where Xia Zhao may publish in the future.

Co-authorship network of co-authors of Xia Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Zhao. A scholar is included among the top collaborators of Xia Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Zhao. Xia Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhanced curcumin delivery behavior of starch-based emulsion-filled gel by granular and molecular starch transformation: From gel formation to controlled release 2025 ·Carbohydrate Polymers ·Xiaofei Wu, (unknown), Xiaoqi Zhao, Yu Hou, Yujia Zhang, Xueqiang Liu, (unknown), Dandan Zhao, Wei Wang, Jianxiong Hao, Xia Zhao	2
2	The Financial Toxicity Experience of Patients with Colorectal Cancer During Chemotherapy: A Qualitative Study 2024 ·Current Oncology ·Yanli Yao, (unknown), (unknown), Xia Zhao, (unknown)	0
3	Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis 2022 ·Cancer Communications ·Xiao Liang, Min Luo, Bin Shao, (unknown), Tong An, (unknown), (unknown), (unknown), Ting Liu, Tao Yi, Xia Zhao, Yuquan Wei, Xiawei Wei	39
4	Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy 2022 ·Molecular Cancer ·Tianxia Lan, Haiying Que, Min Luo, Xia Zhao, Xiawei Wei	20
5	Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis 2018 ·Proceedings of the National Academy of Sciences ·Linjie Zhao, Shuang Huang, Shenglin Mei, Zhengnan Yang, Lian Xu, Nianxin Zhou, Qilian Yang, Qiuhong Shen, Wei Wang, Xiaobing Le, Wayne Bond Lau, Bonnie Lau, Xin Wang, Tao Yi, Xia Zhao, Yuquan Wei, Margaret Warner, Jan-Ακε Gustafsson, Shengtao Zhou	60
6	Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer 2018 ·Oncogene ·Linjie Zhao, Wei Wang, Lian Xu, Tao Yi, Xia Zhao, Yuquan Wei, Louis Vermeulen, Ajay Goel, Shengtao Zhou, Xin Wang	42
7	Epigenetics in ovarian cancer: premise, properties, and perspectives 2018 ·Molecular Cancer ·Qilian Yang, Yuqing Yang, Nianxin Zhou, Ke-Xin Tang, Wayne Bond Lau, Bonnie Lau, Wei Wang, Lian Xu, Zhengnan Yang, Shuang Huang, Xin Wang, Tao Yi, Xia Zhao, Yuquan Wei, Hongjing Wang, Linjie Zhao, Shengtao Zhou	89
8	MicroRNA-18a inhibits ovarian cancer growth via directly targeting TRIAP1 and IPMK 2017 ·Oncology Letters ·(unknown), Xiaorong Qi, Ce Bian, Fan Yang, Xiaojuan Lin, Shengtao Zhou, Chuan Xie, Xia Zhao, Tao Yi	33
9	Tumor microenvironment: The culprit for ovarian cancer metastasis? 2016 ·Cancer Letters ·Zhongyue Luo, (unknown), Wayne Bond Lau, Bonnie Lau, Lian Xu, Linjie Zhao, Huiliang Yang, Min Feng, Xuan Yu, Yanfei Yang, Lingzi Lei, Chenlu Wang, Tao Yi, Xia Zhao, Yuquan Wei, Shengtao Zhou	144
10	VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein 2016 ·International Journal of Oncology ·Xiaorong Qi, (unknown), Xiancheng Chen, Lijuan Chen, Tao Yi, Xiang Chen, Yanjun Wen, Yuquan Wei, Xia Zhao	11
11	Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels 2015 ·International Journal of Medical Sciences ·Yu Bai, Maling Gou, Tao Yi, Li Yang, Lili Liu, Xiaojuan Lin, Dan Su, Yuquan Wei, Xia Zhao	18
12	Antitumor effect of D-erythrose in an abdominal metastatic model of colon carcinoma 2014 ·Oncology Letters ·(unknown), Tao Yi, Xia Zhao	8
13	Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo 2011 ·Nanoscale ·Maling Gou, Ke Men, Shi H, Mingli Xiang, Juan Zhang, Jia Song, Jianlin Long, Yang Wan, Feng Luo, Xia Zhao, Zhiyong Qian	348
14	Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells 2010 ·Cancer Research ·Xiaojun Yang, Xiaojuan Lin, Xiaomin Zhong, Sippy Kaur, Ning Li, Shun Liang, Heini Lassus, Liping Wang, Dionyssios Katsaros, Kathleen T. Montone, Xia Zhao, Youcheng Zhang, Ralf Bützow, George Coukos, Lin Zhang	139
15	A novel strategy for tumour therapy combining cell apoptosis and active immunity induced by caspy2, a zebrafish caspase 2009 ·Journal of Cellular and Molecular Medicine ·Lei Liu, Hongxin Deng, Yongsheng Wang, Ping Chen, Yang Yang, Hanshuo Yang, Xiancheng Chen, Lijuan Chen, Wen Zhu, (unknown), Jinliang Yang, Zhiyong Qian, Jiong Li, Yanjun Wen, Bin Kan, Yong-Qiu Mao, Xia Zhao, Yuquan Wei	3
16	Efficient Inhibition of Ovarian Cancer Growth and Prolonged Survival by Transfection with a Novel Pro-Apoptotic Gene, hPNAS-4, in a Mouse Model 2008 ·Oncology ·Fan Yang, Zhengyu Li, Hongxin Deng, Hanshuo Yang, Fei Yan, Zhiyong Qian, Lijuan Chen, Yuquan Wei, Xia Zhao	11
17	Proteomics Identification of Cyclophilin A as a Potential Prognostic Factor and Therapeutic Target in Endometrial Carcinoma 2008 ·Molecular & Cellular Proteomics ·Zhengyu Li, Xia Zhao, (unknown), Zhi Wang, Lijuan Chen, Yuquan Wei, Canhua Huang	101
18	Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma 2007 ·International Journal of Gynecological Cancer ·(unknown), (unknown), Xinjia He, Linyu Fan, Guangjie Yang, Xing Chen, Xiaoyi Lin, (unknown), Zhen Li, (unknown), (unknown), Xia Zhao, Yuquan Wei	44
19	Grassland recovery by protection from grazing in a semi‐arid sandy region of northern China 2005 ·New Zealand Journal of Agricultural Research ·(unknown), (unknown), Xia Zhao, Gang Xie, Ting Zhang	28
20	INDUCTION OF T CELL RESPONSES AGAINST AUTOLOGOUS OVARIAN TUMORS WITH WHOLE TUMOR CELL LYSATE-PULSED DENDRITIC CELLS 2001 ·Immunological Investigations ·Xia Zhao, Yuquan Wei, (unknown)	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact